NASDAQ:GRTS
Delisted

Gritstone Oncology Stock News

etoro logo Buy GRTS
*Your capital is at risk
$0.0322
+0 (+0%)
At Close: Nov 05, 2024
In a report released yesterday, Marc Frahm from Cowen & Co. maintained a Buy rating on Gritstone Oncology (GRTS). The company's shares closed last
In a report released yesterday, Marc Frahm from Cowen & Co. maintained a Buy rating on Gritstone Oncology (GRTS –
The investment was made through the NEO EcoBoost program, an ecosystem funding effort run by NEO and several partners.
CEX.IO is going to list two cryptocurrencies at once: NEO and GAS. Soon we will enable deposits and NEO/USD and GAS/USD trading.
EMERYVILLE, Calif., Jan. 08, 2020 -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Thera
-- Preliminary results demonstrate unprecedented levels of primed CD8+ neoantigen-specific cytotoxic T cells and expansion of pre-existing T cells even in low-dose cohorts ----.
NEO coin has started an uptrend with a notable escalation. If the current trend remains intact, the price may touch $9.25 soon.
EMERYVILLE, Calif., Dec. 09, 2019 -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight.
This technical analysis evaluates whether NEO, Ontology, and VeChain are bound for a further advance following the recent downturn.
EMERYVILLE, Calif., Nov. 26, 2019 -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight.
Cryptos with links to China are seeing huge leaps as the rest of the market remains relatively quiet, thanks to some recent events that
Gritstone Oncology, Inc. (GRTS) delivered earnings and revenue surprises of -13.24% and -18.00%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE